Last reviewed · How we verify

DP — Competitive Intelligence Brief

DP (DP) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Betalactam antibiotic. Area: Infectious diseases.

marketed Betalactam antibiotic transpeptidase Infectious diseases Small molecule Live · refreshed every 30 min

Target snapshot

DP (DP) — Medecins Sans Frontieres, Netherlands. DP is a medication used to treat certain types of infections caused by bacteria.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
DP TARGET DP Medecins Sans Frontieres, Netherlands marketed Betalactam antibiotic transpeptidase
Aspirin acetylsalicylic acid Bayer AG marketed NSAID, Antiplatelet agent Gamma-glutamyltranspeptidase 1, Nicotinate phosphoribosyltransferase, Acid-sensing ion channel 3 1899-03-06

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Betalactam antibiotic class)

  1. Medecins Sans Frontieres, Netherlands · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). DP — Competitive Intelligence Brief. https://druglandscape.com/ci/dp. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: